Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-007969
Filing Date
2022-05-10
Accepted
2022-05-10 07:27:16
Documents
71
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ispc-20220331x10q.htm   iXBRL 10-Q 1310292
2 EX-31.1 ispc-20220331xex31d1.htm EX-31.1 17354
3 EX-31.2 ispc-20220331xex31d2.htm EX-31.2 13605
4 EX-32.1 ispc-20220331xex32d1.htm EX-32.1 6662
5 EX-32.2 ispc-20220331xex32d2.htm EX-32.2 6508
  Complete submission text file 0001558370-22-007969.txt   5808205

Data Files

Seq Description Document Type Size
6 EX-101.SCH ispc-20220331.xsd EX-101.SCH 42609
7 EX-101.CAL ispc-20220331_cal.xml EX-101.CAL 45340
8 EX-101.DEF ispc-20220331_def.xml EX-101.DEF 197537
9 EX-101.LAB ispc-20220331_lab.xml EX-101.LAB 400499
10 EX-101.PRE ispc-20220331_pre.xml EX-101.PRE 352335
65 EXTRACTED XBRL INSTANCE DOCUMENT ispc-20220331x10q_htm.xml XML 856122
Mailing Address 450 BEDFORD STREET SUITE 1010 LEXINGTON MA 02420
Business Address 450 BEDFORD STREET SUITE 1010 LEXINGTON MA 02420 781-301-6700
iSpecimen Inc. (Filer) CIK: 0001558569 (see all company filings)

EIN.: 270480143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40501 | Film No.: 22907361
SIC: 8731 Services-Commercial Physical & Biological Research